Thermo Fisher Scientific, a Massachusetts-based CDMO giant, inked a collaboration deal with biotech startup Mirai Bio to ...

Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing resources to domestic operations as ongoing US tariffs risk destabilising ...

Shares of Thermo Fisher Scientific Inc. TMO rallied 1.76% to $412.06 Friday, on what proved to be an all-around great trading ...

Thermo Fisher is facing macro headwinds, but execution remains solid. Click here to read why I’m maintaining my Buy rating ...

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter results above analysts' expectations.

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug manufacturing.

Headquartered in Waltham, Massachusetts, Thermo Fisher employed nearly 2,300 employees on its research campus as of last ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an ...

Thermo Fisher Scientific posted 14% net-income growth in the first quarter as revenue inched up and costs remained stable. The Waltham, Mass., maker of microscopes and other life-sciences and ...

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other best stocks that will always grow. Threats of an impending recession are looming ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2025 results beating Wall Street’s revenue expectations , but sales were flat year on year at $10.36 billion. Its non-GAAP profit of ...

Scientists at Thermo Fisher Scientific focus on continually expanding and improving the available assays that bioprocessors can use. One of these assays applies to bioprocesses that use the HEK293 ...